Health
Results: 493-504 of 6058

ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis

Improving gum health could potentially prevent over 300,000 cases of type 2 diabetes and save the NHS almost £2.7 billion over the next decade

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies
